Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma: A Pragmatic Trial

Author： Wilson Edward C.F.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.7, 2010-07, pp. : 597-608

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy: A Pragmatic Trial

By Wilson Edward C.F.  

PharmacoEconomics, Vol. 28, Iss. 7, 2010-07 ,pp. : 585-595

Adis International

Access to resources Recommend Favorite

Inhaled corticosteroids plus long-acting &bgr;2-agonists as a combined therapy in asthma

By García-Marcos Luis   Schuster Antje   Barroso Nicolás Cobos  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 1, 2003-01 ,pp. : 23-39

Informa Healthcare

Access to resources Recommend Favorite

Advances in Asthma and COPD Treatment: Combination Therapy with Inhaled Corticosteroids and Long-Acting &bgr;2-Agonists.

By  

Current Pharmaceutical Design, Vol. 12, Iss. 25, 2006-01 ,pp. : 3261-3279

Bentham Science Publishers

Access to resources Recommend Favorite

Long-Acting Beta-Agonists and their Association with Inhaled Corticosteroids in COPD

By  

Current Medicinal Chemistry, Vol. 20, Iss. 12, 2013-06 ,pp. : 1477-1495

Bentham Science Publishers

Access to resources Recommend Favorite

Nocturnal Asthma Uncontrolled by Inhaled Corticosteroids: Theophylline or Long-Acting Agonists?

By Holimon T.D.  

Drugs, Vol. 61, Iss. 3, 2001-01 ,pp. : 391-418

Adis International

Access to resources Recommend Favorite